Clinical Trials on Sebaceous Hyperplasia

Total 2209 results

Samsung Medical Center

Completed

Retrospective Review a Comprehensive Case Database of HoLEP Procedure Performed by a Single Surgeon

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Korea, Republic of
Urology of Virginia
GlaxoSmithKline

Unknown

Dutasteride for Improving Peri-Operative and Long-Term Outcomes of Photoselective Vaporization of the Prostate (DOP)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

United States
University Hospital Schleswig-Holstein

Withdrawn

Gene Polymorphisms Influencing Steroid Synthesis and Action

Disorders of Sex Development | Congenital Adrenal Hyperplasia | Adrenal Insufficiency | Congenital Adrenal Hypoplasia | Mineralocorticoid Deficiency | Intersex
Assistance Publique - Hôpitaux de Paris
Merck Sharp & Dohme LLC

Completed

Assessment of Prostatic Tissue Concentration of Ertapenem After a Pre-operative Administration (ERTAPRO)

Benign Prostatic Hyperplasia (BPH) Requiring Surgical Resection

France
Centre hospitalier de l'Université de Montréal...
PROCEPT BioRobotics

Recruiting

AQUABEAM® Robotic System and Ultrasound Accessories (AQUA)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Canada
University of Rome Tor Vergata

Recruiting

Focal Laser Ablation for Benign Prostatic Hyperplasia

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Italy
Dominik Abt

Recruiting

Database for the Assessment of Efficacy and Safety of BPH Treatment (KSSG-BPH-REG)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Switzerland
University of California, San Francisco
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Active, not recruiting

Deprescribing Tamsulosin in Older Men (PERSONAL)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

United States
Jeil Pharmaceutical Co., Ltd.

Completed

Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Korea, Republic of
Astellas Pharma Europe B.V.

Completed

Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms (Neptune II)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Belgium, Italy, France, Austria, United Kingdom, Netherlands, Poland, Slovakia, Belarus, Germany, Czechia
Astellas Pharma Europe B.V.

Completed

Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms (Neptune)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Belgium, Italy, France, Austria, United Kingdom, Netherlands, Hungary, Russian Federation, Poland, Slovakia, Czech Republic, Belarus, Germany
Health Ever Bio-Tech Co., Ltd.

Completed

Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS-2-TWN-c)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Taiwan
Seoul National University Hospital
Astellas Pharma Korea, Inc.; Medical Research Collaborating Center, Seoul,...

Unknown

Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) Patients (ABSOLUTE)

Benign Prostate Hyperplasia

Korea, Republic of
Light Sciences Oncology

Completed

Phase 1 Study of the Litx™ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

United States
Light Sciences Oncology

Completed

Study of Light-Activated Talaporfin Sodium in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

New Zealand, Australia
Samsung Medical Center

Completed

Impact of 80 W KTP Laser Vaporization Prostatectomy on Severity of Obstruction in Benign Prostatic Hyperplasia

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Korea, Republic of
JW Pharmaceutical

Completed

Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia | Nocturia

Korea, Republic of
Warner Chilcott

Completed

Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Siami, Paul F., M.D.
GlaxoSmithKline; Pfizer

Completed

Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS) (LUTS)

Benign Prostatic Hyperplasia (BPH)

United States
Boehringer Ingelheim

Completed

FLOMAX® Versus Placebo, in Male Patients With Acute Urinary Retention Related to Benign Prostatic Hyperplasia (BPH)

Prostate Hyperplasia
Franklin D. Gaylis, MD Inc.

Completed

Treatment of Refractory Urinary Retention Secondary to Benign Prostatic Hyperplasia (BPH) With Dual Five Alpha Reductase Inhibition Combined With an Alpha Blocker (AUR)

Benign Prostatic Hyperplasia | Urinary Retention
Medical University of Vienna

Unknown

Self-expanding Nitinol Stents of High vs. Low Chronic Outward Force in De-novo Femoropopliteal Occlusive Arterial Lesions (BIOFLEX-COF)

Stent Restenosis | Intimal Hyperplasia

Austria
Baylor Research Institute
Albert Einstein Healthcare Network

Not yet recruiting

Role of Prophylactic Postoperative Antibiotics in HoLEP

Benign Prostatic Hyperplasia | Urinary Tract Infections

United States
Samsung Medical Center

Completed

Efficacy Study of HoLEP and TURP on LUTS Secondary to BPH

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Korea, Republic of
Sanofi

Completed

The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate Score (ALF-ACUTE)

Benign Prostatic Hyperplasia

United States
Pharma Power Biotec Co., Ltd.

Completed

A Study to Evaluate the Efficacy and Safety of Radion™-Pdt in Patients With Oral Precancerous Lesion

Erythroleukoplakia of Mouth | Verrucous Hyperplasia of Oral Mucosa

Taiwan
University of Kansas Medical Center

Not yet recruiting

Moses Vaporization: Is Use of Moses 2.0 in Holmium Laser Ablation of the Prostate More Efficient (Moses 2)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia
University of Minnesota

Completed

Prostate Artery Embolization (PAE) for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia

United States
Andrew Picel

Withdrawn

Prostatic Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

United States
PROCEPT BioRobotics

Unknown

UK Post-market Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

United Kingdom
Mansoura University

Completed

HoLEP vs. Greenlight 532nm-laser PVEP vs. Bipolar TURP in Management of Moderate/ Large BPH

Lower Urinary Tract Symptoms | Benign Prostate Hyperplasia

Egypt
Maastricht University Medical Center
Yamanouchi

Completed

Effectiveness of a Treatment Protocol for Lower Urinary Tract Symptoms in General Practice

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Netherlands
Health Ever Bio-Tech Co., Ltd.

Completed

MCS in the Treatment of Lower Urinary Tract Symptoms (MCS_LUTS)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

United States
Health Ever Bio-Tech Co., Ltd.

Completed

Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS-2-US-c) (MCS-2-US-c)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

United States
Royal Victoria Hospital, Canada

Unknown

Prostatic Artery Embolization Versus 532 nm Green Light PVP for Catheterized Patients

Benign Prostate Hyperplasia | Urinary Retention

Canada
Health Ever Bio-Tech Co., Ltd.

Terminated

MCS in Treating Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

Taiwan
Sanofi

Completed

Dose Ranging Study of Alfuzosin in Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

Japan
Hospital Universitari Vall d'Hebron Research Institute

Recruiting

Application of MOSES Technology in BPH

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia (BPH)

Spain
Dominik Abt

Not yet recruiting

Prostatic Artery Embolization vs. Pharmacotherapy for LUTS/BPH (EMPATHY)

Benign Prostatic Hyperplasia | Pharmacotherapy | Prostatic Artery Embolization | Minimally Invasive Treatment
Xiaojun Chen
Huashan Hospital

Withdrawn

Liraglutide Plus Megestrol Acetate in Endometrial Atypical Hyperplasia

Atypical Endometrial Hyperplasia | Fertility Issues | Obese
Chinese University of Hong Kong
Koelis

Recruiting

BETTY: BEnign Prostatic Hyperplasia Transperineal Targeted Microwave therapY

Prostate Hyperplasia

Hong Kong
Singapore General Hospital

Recruiting

A Prospective, Randomized Controlled Trial of Stent Graft and Drug Coated Balloon Treatment for Recurrent Cephalic Arch Stenosis in Dysfunctional Arteriovenous-venous Fistula (PREDATOR)

Dialysis Access Malfunction | Neointimal Hyperplasia

Singapore, Australia
University of Mississippi Medical Center

Recruiting

Prostate Artery Embolization: Single Center Experience

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia (BPH)

United States
IMBiotechnologies Ltd.

Completed

Safety and Efficacy of OCL 503 in Prostate Artery Embolization

Benign Prostatic Hyperplasia | Benign Prostatic Hypertrophy

Canada
Sophiris Bio Corp

Completed

Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH (PLUS-1)

Benign Prostatic Hyperplasia

United States, Australia, Canada, Russian Federation, Ukraine, New Zealand
Sophiris Bio Corp

Completed

Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia

United States
RDC Clinical Pty Ltd

Recruiting

Comparison of 2 Extracts of Saw Palmetto Versus Placebo on BPH Symptoms

Benign Prostatic Hyperplasia

Australia
Thunder Bay Regional Health Research Institute

Recruiting

Thulium Fiber Laser (TFL) vs Holmium MOSES for Treatment of Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia

Canada
Centre Hospitalier Universitaire de Nice

Active, not recruiting

Prostatic Arterial Embolization With SQUID (Ethylene Vinyl Alcohol Copolymer ) (SQUID)

Prostatic Hyperplasia, Benign

France
Weill Medical College of Cornell University
Boston Scientific Corporation

Suspended

Catheterless Water Vapor Therapy for the Treatment of BPH

Benign Prostatic Hyperplasia

United States

Clinical Trials on Sebaceous Hyperplasia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Philippines

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations